Department of Neurosurgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
J Neurosci Res. 2019 Jul;97(7):828-845. doi: 10.1002/jnr.24413. Epub 2019 Mar 20.
Oligodendrocytes (OLs) show heterogeneous properties that depend on their location in the central nervous system (CNS). In this regard, the investigation of oligodendrocyte precursor cells (OPCs) derived from human pluripotent stem cells (hPSCs) should be reconsidered, particularly in cases of brain-predominant disorders for which brain-derived OPCs are more appropriate than spinal cord-derived OPCs. Furthermore, animal-derived components are responsible for culture variability in the derivation and complicate clinical translation. In the present study, we established a xeno-free system to induce forebrain OPCs from hPSCs. We induced human forebrain neural stem cells (NSCs) on Laminin 511-E8 and directed the differentiation to the developmental pathway for forebrain OLs with SHH and FGF signaling. OPCs were characterized by the expression of OLIG2, NKX2.2, SOX10, and PDGFRA, and subsequent maturation into O4 cells. In vitro characterization showed that >85% of the forebrain OPCs (O4 ) underwent maturation into OLs (MBP ) 3 weeks after mitogen removal. Upon intracranial transplantation, the OPCs survived, dispersed in the corpus callosum, and matured into (GSTπ ) OLs in the host brains 3 months after transplantation. These findings suggest our xeno-free induction of forebrain OPCs from hPSCs could accelerate clinical translation for brain-specific disorders.
少突胶质细胞(OLs)表现出依赖于其在中枢神经系统(CNS)中位置的异质性特性。在这方面,应该重新考虑从人多能干细胞(hPSCs)中衍生的少突胶质前体细胞(OPCs)的研究,特别是在以大脑为主的疾病中,脑源性 OPCs 比脊髓源性 OPCs 更合适。此外,动物源性成分是导致衍生培养变异性的原因,并使临床转化复杂化。在本研究中,我们建立了一个无动物成分的系统,从 hPSCs 中诱导前脑 OPCs。我们在层粘连蛋白 511-E8 上诱导人前脑神经干细胞(NSCs),并通过 SHH 和 FGF 信号诱导其向前脑 OL 发育途径分化。OPCs 通过 OLIG2、NKX2.2、SOX10 和 PDGFRA 的表达来表征,并随后成熟为 O4 细胞。体外表征显示,在有丝分裂原去除 3 周后,>85%的前脑 OPCs(O4)成熟为 OLs(MBP)。颅内移植后,OPCs 存活,在胼胝体中分散,并在移植后 3 个月在宿主大脑中成熟为(GSTπ)OLs。这些发现表明,我们从 hPSCs 中无动物成分诱导前脑 OPCs 可以加速针对大脑特异性疾病的临床转化。